Participant guide
Informed consent explained
Informed consent is how you learn what a colorectal cancer study involves before you decide whether to take part. Think of it as a conversation with the study team. The signature is only one piece of it.
Updated
What you are told
Nothing gets signed first. The team running the colorectal cancer study talks you through it, then hands you the consent document in writing so you can read it for yourself before you decide. Expect it to spell out:
- the reason for the study and its length;
- your part in it, meaning the tasks, the tests and the visits;
- known discomforts and risks;
- what benefits, if any, could reasonably be expected;
- alternatives available to you apart from the study;
- the way your information is kept confidential;
- the person to reach when a concern or a question comes up.
Take your time
The document can go home with you. Go through it with family or your own doctor, and keep asking questions until you have what you need. This list of questions worth asking is a good place to start.
Consent is ongoing
No, your signature does not lock you in. The consent document is no contract. Leaving the study stays your choice at any time. And when something new is learned partway through that could change how you feel about taking part, the team must share it with you.
Talk with a study coordinator
Phone (888) 385-9581, or submit the short form if you prefer. Either way, a coordinator tells you which colorectal cancer studies could be a fit and lays out what happens next. You can ask as much as you like without being tied to anything.
Sources and further reading
- About Research Participation — HHS Office for Human Research Protections
- Clinical Research: Benefits, Risks, and Safety — National Institute on Aging (NIH)
- 45 CFR 46 — Protection of Human Subjects — U.S. Department of Health and Human Services